Table: Chugai Pharm -2025 group results (IFRS)

Chugai Pharmaceutical

29/01/2026 08:00

Jan 29 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2025    Dec 31, 2024   Dec 31, 2026      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales           1.26 trln       1.17 trln                              
                 (+7.5 pct)      (+5.3 pct)                              
  Operating        598.83          542.00                                
                 (+10.5 pct)     (+23.4 pct)                             
  Pretax
  Net              434.01          387.32                                
                 (+12.1 pct)     (+19.0 pct)                             
  EPS Basic      263.73 yen      235.39 yen                              
  EPS Diluted    263.72 yen      235.36 yen                              
  Ann Div        272.00 yen       98.00 yen     132.00 yen               
  -Q2 Div        125.00 yen       41.00 yen      66.00 yen               
  -Q4 Div        147.00 yen       57.00 yen      66.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T